As of 2024-12-15, the Relative Valuation of Crinetics Pharmaceuticals Inc (CRNX) is (43.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 55.62 USD, the upside of Crinetics Pharmaceuticals Inc based on Relative Valuation is -178.8%.
The range of the Relative Valuation is (51.24) - (52.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 17.5x | 17.3x |
| Forward P/E multiples | 5.1x - 18.8x | 12.0x |
| Fair Price | (51.24) - (52.44) | (43.83) |
| Upside | -192.1% - -194.3% | -178.8% |
| Date | P/E |
| 2024-12-13 | -17.99 |
| 2024-12-12 | -18.56 |
| 2024-12-11 | -20.07 |
| 2024-12-10 | -19.08 |
| 2024-12-09 | -18.89 |
| 2024-12-06 | -19.65 |
| 2024-12-05 | -19.25 |
| 2024-12-04 | -19.06 |
| 2024-12-03 | -18.88 |
| 2024-12-02 | -19.15 |
| 2024-11-29 | -19.09 |
| 2024-11-27 | -19.24 |
| 2024-11-26 | -18.94 |
| 2024-11-25 | -18.72 |
| 2024-11-22 | -18.71 |
| 2024-11-21 | -19.03 |
| 2024-11-20 | -18.71 |
| 2024-11-19 | -18.41 |
| 2024-11-18 | -17.92 |
| 2024-11-15 | -18.26 |
| 2024-11-14 | -19.91 |
| 2024-11-13 | -19.66 |
| 2024-11-12 | -19.62 |
| 2024-11-11 | -20.03 |
| 2024-11-08 | -20.25 |
| 2024-11-07 | -19.96 |
| 2024-11-06 | -19.74 |
| 2024-11-05 | -19.29 |
| 2024-11-04 | -18.96 |
| 2024-11-01 | -18.92 |
| 2024-10-31 | -18.67 |
| 2024-10-30 | -18.61 |
| 2024-10-29 | -18.77 |
| 2024-10-28 | -19.07 |
| 2024-10-25 | -19.34 |
| 2024-10-24 | -19.60 |
| 2024-10-23 | -19.49 |
| 2024-10-22 | -19.89 |
| 2024-10-21 | -19.59 |
| 2024-10-18 | -19.72 |
| 2024-10-17 | -19.66 |
| 2024-10-16 | -19.64 |
| 2024-10-15 | -19.22 |
| 2024-10-14 | -17.72 |
| 2024-10-11 | -17.73 |
| 2024-10-10 | -17.28 |
| 2024-10-09 | -16.92 |
| 2024-10-08 | -17.25 |
| 2024-10-07 | -17.27 |
| 2024-10-04 | -17.73 |